Table 2.
Prevalence of genotype-specific HPV infection among pregnant women at first trimester.
| HPV genotype | n | % (n type+/n) | 95% LCI | 95% HCI |
|---|---|---|---|---|
| 6 | 1 | 0.6 | 0.0 | 3.3 |
| 11 | 0 | 0.0a | 0.0 | 2.2 |
| 16 | 10 | 6.0 | 2.9 | 10.7 |
| 18 | 7 | 4.2 | 1.7 | 8.4 |
| 26 | 0 | 0.0a | 0.0 | 2.2 |
| 31 | 12 | 7.2 | 3.8 | 12.2 |
| 33 | 3 | 1.8 | 0.4 | 5.2 |
| 34 | 1 | 0.6 | 0.0 | 3.3 |
| 35 | 3 | 1.8 | 0.4 | 5.2 |
| 39 | 11 | 6.6 | 3.3 | 11.5 |
| 40 | 3 | 1.8 | 0.4 | 5.2 |
| 42 | 8 | 4.8 | 2.1 | 9.2 |
| 44 | 5 | 3.0 | 1.0 | 6.8 |
| 45 | 2 | 1.2 | 0.1 | 4.3 |
| 51 | 7 | 4.2 | 1.7 | 8.4 |
| 52 | 8 | 4.8 | 2.1 | 9.2 |
| 53 | 10 | 6.0 | 2.9 | 10.7 |
| 54 | 7 | 4.2 | 1.7 | 8.4 |
| 56 | 3 | 1.8 | 0.4 | 5.2 |
| 58 | 6 | 3.6 | 1.3 | 7.7 |
| 59 | 9 | 5.4 | 2.5 | 10.0 |
| 61 | 5 | 3.0 | 1.0 | 6.8 |
| 62 | 11 | 6.6 | 3.3 | 11.5 |
| 66 | 4 | 2.4 | 0.7 | 6.0 |
| 67 | 3 | 1.8 | 0.4 | 5.2 |
| 68 | 2 | 1.2 | 0.1 | 4.3 |
| 69 | 0 | 0.0a | 0.0 | 2.2 |
| 70 | 2 | 1.2 | 0.1 | 4.3 |
| 71 | 2 | 1.2 | 0.1 | 4.3 |
| 72 | 0 | 0.0a | 0.0 | 2.2 |
| 73 | 6 | 3.6 | 1.3 | 7.7 |
| 81 | 1 | 0.6 | 0.0 | 3.3 |
| 82 | 3 | 1.8 | 0.4 | 5.2 |
| 83 | 4 | 2.4 | 0.7 | 6.0 |
| 84 | 5 | 3.0 | 1.0 | 6.8 |
| 89 | 14 | 8.4 | 4.7 | 13.7 |
| HPV groups | ||||
| Any HPV | 75 | 44.9 | 37.2 | 52.8 |
| HR-HPV | 56 | 33.5 | 26.4 | 41.2 |
| LR HPV only | 19 | 11.4 | 7.0 | 17.2 |
| ß-globin negative | 0 | 0 | ||
n, number; LCI, low confidence interval; HCI, high confidence interval; HR-, high-oncogenic risk; LR-, low-oncogenic risk.
a
One-sided, 97.5% confidence interval.